ABBVIE INC (4AB.DE) Fundamental Analysis & Valuation
FRA:4AB • US00287Y1091
Current stock price
170.85 EUR
-1.05 (-0.61%)
Last:
This 4AB.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 4AB.DE Profitability Analysis
1.1 Basic Checks
- 4AB had positive earnings in the past year.
- 4AB had a positive operating cash flow in the past year.
- 4AB had positive earnings in each of the past 5 years.
- In the past 5 years 4AB always reported a positive cash flow from operatings.
1.2 Ratios
- 4AB's Return On Assets of 3.12% is fine compared to the rest of the industry. 4AB outperforms 75.31% of its industry peers.
- With an excellent Return On Invested Capital value of 14.42%, 4AB belongs to the best of the industry, outperforming 90.12% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for 4AB is in line with the industry average of 12.00%.
- The last Return On Invested Capital (14.42%) for 4AB is above the 3 year average (12.12%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROIC | 14.42% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
1.3 Margins
- 4AB's Profit Margin of 6.84% is fine compared to the rest of the industry. 4AB outperforms 75.31% of its industry peers.
- 4AB's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 34.23%, 4AB belongs to the top of the industry, outperforming 90.12% of the companies in the same industry.
- 4AB's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 71.62%, 4AB is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
- In the last couple of years the Gross Margin of 4AB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% |
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
2. 4AB.DE Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 4AB is creating some value.
- Compared to 1 year ago, 4AB has about the same amount of shares outstanding.
- The number of shares outstanding for 4AB remains at a similar level compared to 5 years ago.
- The debt/assets ratio for 4AB is higher compared to a year ago.
2.2 Solvency
- 4AB has an Altman-Z score of 2.24. This is not the best score and indicates that 4AB is in the grey zone with still only limited risk for bankruptcy at the moment.
- 4AB has a Altman-Z score (2.24) which is in line with its industry peers.
- 4AB has a debt to FCF ratio of 3.79. This is a good value and a sign of high solvency as 4AB would need 3.79 years to pay back of all of its debts.
- 4AB's Debt to FCF ratio of 3.79 is amongst the best of the industry. 4AB outperforms 83.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Altman-Z | 2.24 |
ROIC/WACC1.61
WACC8.95%
2.3 Liquidity
- 4AB has a Current Ratio of 0.67. This is a bad value and indicates that 4AB is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.67, 4AB is doing worse than 83.95% of the companies in the same industry.
- A Quick Ratio of 0.56 indicates that 4AB may have some problems paying its short term obligations.
- 4AB has a Quick ratio of 0.56. This is amonst the worse of the industry: 4AB underperforms 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 |
3. 4AB.DE Growth Analysis
3.1 Past
- 4AB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.19%.
- Measured over the past years, 4AB shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.99% on average per year.
- The Revenue has grown by 8.57% in the past year. This is quite good.
- The Revenue has been growing slightly by 5.95% on average over the past years.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
3.2 Future
- 4AB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.08% yearly.
- Based on estimates for the next years, 4AB will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. 4AB.DE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 19.98 indicates a rather expensive valuation of 4AB.
- Based on the Price/Earnings ratio, 4AB is valued cheaper than 82.72% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.47. 4AB is valued slightly cheaper when compared to this.
- 4AB is valuated correctly with a Price/Forward Earnings ratio of 13.47.
- Based on the Price/Forward Earnings ratio, 4AB is valued cheaper than 95.06% of the companies in the same industry.
- 4AB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.62, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.98 | ||
| Fwd PE | 13.47 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 4AB is valued cheaper than 82.72% of the companies in the same industry.
- 91.36% of the companies in the same industry are more expensive than 4AB, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.84 | ||
| EV/EBITDA | 14.28 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of 4AB may justify a higher PE ratio.
- 4AB's earnings are expected to grow with 22.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y28.1%
EPS Next 3Y22.01%
5. 4AB.DE Dividend Analysis
5.1 Amount
- 4AB has a Yearly Dividend Yield of 3.31%. Purely for dividend investing, there may be better candidates out there.
- 4AB's Dividend Yield is rather good when compared to the industry average which is at 0.63. 4AB pays more dividend than 97.53% of the companies in the same industry.
- 4AB's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
5.2 History
- On average, the dividend of 4AB grows each year by 6.76%, which is quite nice.
Dividend Growth(5Y)6.76%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
- 4AB pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
- The dividend of 4AB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
4AB.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:4AB (4/24/2026, 4:04:29 PM)
170.85
-1.05 (-0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-29 2026-04-29/bmo
Inst Owners76.21%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap302.19B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.95
Price Target217.08 (27.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.31% |
Yearly Dividend5.59
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)0.23%
PT rev (3m)1.88%
EPS NQ rev (1m)-9.13%
EPS NQ rev (3m)-11.91%
EPS NY rev (1m)-0.08%
EPS NY rev (3m)2.02%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.35%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.98 | ||
| Fwd PE | 13.47 | ||
| P/S | 5.78 | ||
| P/FCF | 19.84 | ||
| P/OCF | 18.57 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.28 |
EPS(TTM)8.55
EY5%
EPS(NY)12.68
Fwd EY7.42%
FCF(TTM)8.61
FCFY5.04%
OCF(TTM)9.2
OCFY5.39%
SpS29.57
BVpS-1.58
TBVpS-44.26
PEG (NY)0.41
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.12% | ||
| ROE | N/A | ||
| ROCE | 23.09% | ||
| ROIC | 14.42% | ||
| ROICexc | 15.28% | ||
| ROICexgc | N/A | ||
| OM | 34.23% | ||
| PM (TTM) | 6.84% | ||
| GM | 71.62% | ||
| FCFM | 29.13% |
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.79 | ||
| Debt/EBITDA | 2.11 | ||
| Cap/Depr | 14.92% | ||
| Cap/Sales | 1.98% | ||
| Interest Coverage | 6.97 | ||
| Cash Conversion | 65.45% | ||
| Profit Quality | 425.61% | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.56 | ||
| Altman-Z | 2.24 |
F-Score8
WACC8.95%
ROIC/WACC1.61
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y48.29%
EPS Next 2Y28.1%
EPS Next 3Y22.01%
EPS Next 5Y15.08%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.03%
Revenue Next 2Y9.07%
Revenue Next 3Y8.45%
Revenue Next 5Y6.43%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.08%
EBIT Next 3Y19.31%
EBIT Next 5Y10.21%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%
ABBVIE INC / 4AB.DE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of ABBVIE INC (4AB.DE) stock?
ChartMill assigns a fundamental rating of 5 / 10 to 4AB.DE.
What is the valuation status for 4AB stock?
ChartMill assigns a valuation rating of 8 / 10 to ABBVIE INC (4AB.DE). This can be considered as Undervalued.
Can you provide the profitability details for ABBVIE INC?
ABBVIE INC (4AB.DE) has a profitability rating of 7 / 10.
How financially healthy is ABBVIE INC?
The financial health rating of ABBVIE INC (4AB.DE) is 3 / 10.
What is the earnings growth outlook for ABBVIE INC?
The Earnings per Share (EPS) of ABBVIE INC (4AB.DE) is expected to grow by 48.29% in the next year.